Summit Therapeutics shares owned by Bayesian Capital Management
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Bayesian Capital Management
from 13F filings
Historical chart of Bayesian Capital Management investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Bayesian Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $251k | 17k | 14.57 |
| 2024-12-31 | $1.2M | 67k | 17.85 |
| 2024-06-30 | $129k | 17k | 7.80 |
More positions owned by Bayesian Capital Management
View all positions for Bayesian Capital Management